Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:03 PM ET Form 4
Insider Selling Crescent Biopharma, Inc. CBIO

Crescent Biopharma CMO Ellie Eunkyung Im Sells $11.2K of Stock

Ellie Eunkyung Im, CMO, sold 623 shares of Crescent Biopharma, Inc. at $17.90 a share, worth $11.2K in total on Sep 16, 2026. Shares held after the trade: 21,446 (-2.8%).

Value
$11.2K
Shares
623
Price
$17.90
Role
CMO
Holding change
-2.8%
Trade date
Sep 16, 2026
4:03 PM ET Form 4
Insider Selling Crescent Biopharma, Inc. CBIO

Crescent Biopharma President and COO Jonathan McNeill Sells $77.2K of Stock

Jonathan McNeill, President and COO, sold 4,570 shares of Crescent Biopharma, Inc. at $16.71 to $17.90 a share (average $16.90) in 2 transactions, worth $77.2K in total between Sep 16, 2026 and Sep 18, 2026. Shares held after the trade: 134,588 (-2.8%).

Value
$77.2K
Shares
4,570
Average price
$16.90
Role
President and COO
Holding change
-2.8%
Trade date
Sep 16, 2026 to Sep 18, 2026
4:03 PM ET Form 4
Insider Selling Crescent Biopharma, Inc. CBIO

Crescent Biopharma CFO Richard William Scalzo Sells $10.2K of Stock

Richard William Scalzo, CFO, sold 568 shares of Crescent Biopharma, Inc. at $17.90 a share, worth $10.2K in total on Sep 16, 2026. Shares held after the trade: 19,730 (-2.8%).

Value
$10.2K
Shares
568
Price
$17.90
Role
CFO
Holding change
-2.8%
Trade date
Sep 16, 2026
4:03 PM ET Form 4
Insider Selling Crescent Biopharma, Inc. CBIO

Crescent Biopharma CEO Joshua T. Brumm Sells $160K of Stock

Joshua T. Brumm, CEO, sold 9,447 shares of Crescent Biopharma, Inc. at $16.71 to $17.90 a share (average $16.91) in 2 transactions, worth $160K in total between Sep 16, 2026 and Sep 18, 2026. Shares held after the trade: 271,765 (-2.8%).

Value
$160K
Shares
9,447
Average price
$16.91
Role
CEO
Holding change
-2.8%
Trade date
Sep 16, 2026 to Sep 18, 2026
4:03 PM ET Form 4
Insider Selling Crescent Biopharma, Inc. CBIO

Crescent Biopharma Insider Barbara Harlin Bispham Sells $11.1K of Stock

Barbara Harlin Bispham sold 620 shares of Crescent Biopharma, Inc. at $17.90 a share, worth $11.1K in total on Sep 16, 2026. Shares held after the trade: 18,710 (-3.2%).

Value
$11.1K
Shares
620
Price
$17.90
Holding change
-3.2%
Trade date
Sep 16, 2026
4:03 PM ET Form 4
Insider Selling Kanzhun Ltd BZ

Kanzhun Insider Yang Mu Sells $453K of Stock

Yang Mu sold 60,704 shares of Kanzhun Ltd at $7.46 a share, worth $453K in total on Sep 17, 2026. Shares held after the trade: 143,356 (-29.7%).

Value
$453K
Shares
60,704
Price
$7.46
Holding change
-29.7%
Trade date
Sep 17, 2026
4:03 PM ET Form 4
Insider Selling Proto Labs Inc PRLB

Proto Labs CFO Daniel Schumacher Sells $418K of Stock

Daniel Schumacher, CFO, sold 4,900 shares of Proto Labs Inc at $85.21 a share, worth $418K in total on Sep 17, 2026. Shares held after the trade: 40,019 (-10.9%).

Value
$418K
Shares
4,900
Price
$85.21
Role
CFO
Holding change
-10.9%
Trade date
Sep 17, 2026
4:02 PM ET 8-K
Court & Legal Update Mercury Systems Inc MRCY

Mercury Systems Court & Legal Update

Mercury Systems received preliminary court approval for the settlement of two consolidated stockholder derivative actions, Jones v. Aslett and McKinnon v. Aslett. The settlement resolves litigation originally agreed upon in July 2026, with the court issuing formal orders granting preliminary approval on September 9 and September 15, 2026.

Counterparty
Essex County Superior Court for the Commonwealth of Massachusetts
4:02 PM ET 8-K
Investor Presentation Fuel Tech, Inc. FTEK

Fuel Tech Investor Presentation

Fuel Tech, Inc. has posted an updated corporate presentation to its website and filed it as an exhibit to this 8-K. The presentation, dated September 14, 2026, provides a strategic overview of the company's operations and technology for investors.

4:02 PM ET 8-K
Dividend Omega Flex, Inc. OFLX

Omega Flex Dividend

Omega Flex, Inc. declared a regular quarterly cash dividend of $0.34 per share for the third quarter of 2026. The dividend is payable on October 14, 2026, to shareholders of record as of the close of business on September 30, 2026.

4:02 PM ET 8-K
Capital Raise KKR FS Income Trust

KKR FS Income Trust Capital Raise of $3.71M

KKR FS Income Trust issued and sold 127,341.992 Class I shares for approximately $3.705 million as part of its ongoing continuous private offering. The company also reported a net asset value (NAV) per share of $29.10 as of August 31, 2026, with total offering proceeds to date reaching approximately $1.769 billion.

Value
$3.71M
Counterparty
Participating investors
4:01 PM ET 8-K
Capital Raise Zoomcar Holdings, Inc. ZCAR

Zoomcar Holdings Capital Raise

Zoomcar Holdings, Inc. completed the sixth closing of its private placement of Series A units, raising approximately $155,000 in gross proceeds. Each unit, sold at $1,000, consists of one share of Series A Convertible Preferred Stock and a warrant to purchase 20,000 shares of common stock. The company has agreed to file a registration statement for the resale of the underlying common stock within 15 days of the closing.

Counterparty
certain accredited investors
4:01 PM ET 8-K
Dividend Carlyle Credit Solutions, Inc.

Carlyle Credit Solutions Dividend

Carlyle Credit Solutions declared a quarterly dividend of $0.14 per share for Class I common stock, payable on October 28, 2026. The company also disclosed it raised $10.3 million through the issuance of 569,592 shares as part of its ongoing continuous private offering and reported a net asset value (NAV) per share of $18.05 as of August 31, 2026.

4:01 PM ET 8-K
Dividend Mesa Royalty Trust MTR

Mesa Royalty Trust Dividend

Mesa Royalty Trust announced that there will be no cash distribution for the month of September 2026. The suspension is due to costs and expenses exceeding royalty revenues from its oil and gas properties, as well as the Trust's ongoing effort to build a $2.0 million cash reserve for liquidity.

Term
September 2026
4:01 PM ET 8-K
Dividend Cemtrex Inc CETX

Cemtrex Dividend

Cemtrex Inc. announced that its Board of Directors has authorized the payment of a semi-annual dividend on its Series 1 Preferred Stock in the form of additional shares of the same stock. The dividend is based on a 10% annual rate on a $10.00 per share preference amount and will be issued on October 7, 2026, to shareholders of record as of September 30, 2026.

4:01 PM ET 8-K
Other 8-K Filing Pro Dex Inc PDEX

Pro Dex Other 8-K Filing

Pro-Dex, Inc. entered into a third amendment to its lease agreement with Irvine Business Properties for its executive offices and manufacturing facility in Irvine, California. The amendment extends the lease term to September 30, 2030, and establishes a schedule for 3.5% annual base rent increases starting in October 2027. This filing ensures the company maintains its primary operational and manufacturing footprint for the next four years.

Counterparty
Irvine Business Properties
Term
through September 30, 2030
4:01 PM ET 8-K/A
Leadership Change Intellinetics, Inc. INLX

Intellinetics Leadership Change

Matthew Chretien retired as Chief Strategy Officer and Secretary effective September 1, 2026, and entered into a separation agreement providing three months' salary as severance. Joseph Spain, the current CFO and Treasurer, has assumed the additional role of Secretary while stepping down as Chief Operating Officer.

4:01 PM ET 8-K
Shareholder Meeting Inhibitor Therapeutics, Inc. INTI

Inhibitor Therapeutics Shareholder Meeting

Inhibitor Therapeutics held its 2026 Annual Meeting of Stockholders on September 15, 2026, where shareholders elected six directors to the board for one-year terms. Stockholders also ratified Cherry Bekaert LLP as the independent auditor, approved the 2025 Share Incentive Plan, and approved executive compensation on an advisory basis.

4:01 PM ET 8-K
Capital Raise North Haven Net REIT

North Haven Net REIT Capital Raise of $4.81M

North Haven Net REIT sold an aggregate of 216,664 Class I shares and 13,137 Class F-I shares to a feeder vehicle for approximately $4.8 million in total consideration. The private placement was conducted based on the company's net asset value per share as of August 31, 2026, and was exempt from registration under Rule 506 of Regulation D.

Value
$4.81M
Counterparty
feeder vehicle
4:00 PM ET 8-K
Capital Raise KKR FS Income Trust Select

KKR FS Income Trust Select Capital Raise of $5.25M

KKR FS Income Trust Select issued and sold 211,475.523 Class I shares for approximately $5.255 million as part of its ongoing continuous private offering. As of September 18, 2026, the company has raised approximately $1.041 billion to date against a total offering target of $5.0 billion.

Value
$5.25M
Counterparty
Participating investors
3:58 PM ET 8-K
Dividend San Juan Basin Royalty Trust SJT

San Juan Basin Royalty Trust Dividend

San Juan Basin Royalty Trust announced it will not declare a monthly cash distribution for September 2026. The suspension is due to excess production costs of approximately $12.55 million gross and continued low natural gas pricing. Distributions will remain suspended until net proceeds are sufficient to repay the excess costs, replenish a $2 million reserve, and repay the Trust's line of credit.

Term
September 2026
3:57 PM ET Form 4
Insider Buying New Peoples Bankshares Inc NWPP

New Peoples Bankshares Insider John D. Cox Buys $58.8K of Stock

John D. Cox bought 12,000 shares of New Peoples Bankshares Inc at $4.90 a share, worth $58.8K in total on Sep 17, 2026. Shares held after the trade: 788,281 (+1.5%).

Value
$58.8K
Shares
12,000
Price
$4.90
Holding change
+1.5%
Trade date
Sep 17, 2026
3:47 PM ET 8-K
Capital Raise Cottonwood Communities, Inc.

Cottonwood Communities Capital Raise of $1.55M

Cottonwood Communities, Inc. issued and sold 162,620 shares of its Series A Convertible Preferred Stock in a private placement offering between September 9 and September 17, 2026. The company received aggregate proceeds of $1.55 million from the sale, which is part of an ongoing private offering of up to $200 million. As of September 17, 2026, there were approximately 13.5 million shares of Series A Convertible Preferred Stock outstanding.

Value
$1.55M
Counterparty
Accredited investors
3:00 PM ET 8-K
Leadership Change Creditriskmonitor Com Inc CRMZ

Creditriskmonitor Com Leadership Change

Jennifer Gerold, the Chief Financial Officer of CreditRiskMonitor.com, Inc., has resigned for personal considerations effective November 17, 2026. Her departure is not due to any disagreement with the company, and she will remain in her role until the effective date to assist with the transition while a search for a replacement is conducted.

2:52 PM ET Form 4
Insider Selling Nutex Health Inc. NUTX

Nutex Health Insider Scott J. Saunders Sells $43.5K of Stock

Scott J. Saunders sold 203 shares of Nutex Health Inc. at $214.25 a share, worth $43.5K in total on Sep 18, 2026. Shares held after the trade: 400 (-33.7%).

Value
$43.5K
Shares
203
Price
$214.25
Holding change
-33.7%
Trade date
Sep 18, 2026
1:32 PM ET Form 4
Insider Selling Scorpio Tankers Inc. STNG

Scorpio Tankers President Robert L. Bugbee Sells $22.2M of Stock

Robert L. Bugbee, President, sold 256,799 shares of Scorpio Tankers Inc. at $86.19 to $87.15 a share (average $86.28) in 2 transactions, worth $22.2M in total between Sep 16, 2026 and Sep 17, 2026. Shares held after the trade: 640,288 (+4.1%).

Value
$22.2M
Shares
256,799
Average price
$86.28
Role
President
Holding change
+4.1%
Trade date
Sep 16, 2026 to Sep 17, 2026
1:25 PM ET 8-K
Shareholder Meeting Exozymes Inc. EXOZ

Exozymes Shareholder Meeting

Exozymes Inc. has scheduled its 2026 Annual Meeting of Shareholders for November 13, 2026. The company established a record date of September 15, 2026, and plans to distribute proxy materials to shareholders on or about September 28, 2026.

1:24 PM ET 8-K
Dividend PermRock Royalty Trust PRT

PermRock Royalty Trust Dividend

PermRock Royalty Trust declared a monthly cash distribution of $238,742.30 ($0.0196242 per unit) payable on October 15, 2026, to holders of record as of September 30, 2026. The distribution is based on oil and natural gas production from the Trust's Permian Basin properties during the month of July 2026.

Term
July 2026
1:08 PM ET 8-K
Loan & Debt Ameren Corp AEE

Ameren $900M Debt Financing with Barclays Capital Inc.

Ameren Corporation completed the sale of $900 million in Junior Subordinated Notes due 2057. The company received net proceeds of approximately $891 million before expenses to be used for general corporate purposes.

Value
$900M
Counterparty
Barclays Capital Inc., BofA Securities, Inc., J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, MUFG Securities Americas Inc. and Truist Securities, Inc.
Term
due 2057

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.